Supplementarty Materials: Real-world safety of Spesolimab: A pharmacovigilance analysis using the FDA Adverse Event Reporting System

Published: 1 November 2026| Version 1 | DOI: 10.17632/3mf7t2jjns.1
Contributors:
,
,
,
, Junguo duan

Description

Supplementarty Materials: Real-world safety of Spesolimab: A pharmacovigilance analysis using the FDA Adverse Event Reporting System

Files

Categories

Psoriasis, Drug Safety, Pharmacovigilance, Disproportionality Analysis

Funders

Licence